BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soraya GV, Ulhaq ZS, Shodry S, A'raaf Sirojan Kusuma M, Herawangsa S, Sativa MO, Gustaf A, Faridwazdi DAN, Florentia SW, Raisa N, Bintang AK, Akbar M. Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis. Neurol Sci 2022;43:3649-70. [PMID: 35079903 DOI: 10.1007/s10072-021-05829-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Dulski J, Uitti RJ, Ross OA, Wszolek ZK. Genetic architecture of Parkinson’s disease subtypes – Review of the literature. Front Aging Neurosci 2022;14:1023574. [DOI: 10.3389/fnagi.2022.1023574] [Reference Citation Analysis]
2 Akbar M, Soraya GV, Ulhaq ZS, Bintang AK. A Roadmap for Future Parkinson's Pharmacogenomics in Asia. Front Aging Neurosci 2022;14:896371. [DOI: 10.3389/fnagi.2022.896371] [Reference Citation Analysis]
3 Fatima TS, Fathima ST, Kandadai RM, Borgohain R, Sreenu B, Kutala VK. Association of Catechol-O-Methyltransferase Gene Polymorphisms and Haplotypes in the Levodopa-Induced Adverse Events in Subjects with Parkinson’s Disease. Ind J Clin Biochem. [DOI: 10.1007/s12291-022-01046-8] [Reference Citation Analysis]